CG Oncology, Inc.
CGON- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001991792
In the last 90 days, CG Oncology, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $6.66B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in CG Oncology, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 142
- +3 vs. Q4 2024
- Shares held
- 70.8M
- +4.65M (+7.0%) vs. Q4 2024
- Total value
- $1.74B
- −$157.0M (−8.3%) vs. Q4 2024
- New holders
- 27
- 61 more added
- Sold out
- 24
- 34 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 227 | $6.66B |
| Q1 2026 | 233 | $6.03B |
| Q4 2025 | 195 | $3.43B |
| Q3 2025 | 176 | $3.13B |
| Q2 2025 | 163 | $1.97B |
| Q1 2025 | 142 | $1.74B |
| Q4 2024 | 140 | $1.90B |
| Q3 2024 | 121 | $1.96B |
| Q2 2024 | 111 | $1.37B |
| Q1 2024 | 96 | $1.70B |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding CG Oncology, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| StemPoint Capital LP | 289,823 | $7.10M | 2.27% | +289,823 | New |
| ADAR1 Capital Management, LLC | 301,134 | $7.37M | 1.42% | +85,384+39.6% | Added |
| Soleus Capital Management, L.P. | 303,585 | $7.43M | 0.58% | −25,000−7.6% | Reduced |
| Bank of America Corp | 340,599 | $8.34M | 0.00% | +131,081+62.6% | Added |
| Charles Schwab Investment Management Inc | 439,278 | $10.8M | 0.00% | +11,518+2.7% | Added |
| Northern Trust Corp | 471,764 | $11.6M | 0.00% | +37,904+8.7% | Added |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 495,526 | $12.1M | 31.67% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 517,258 | $12.7M | 0.20% | −29,646−5.4% | Reduced |
| Saturn V Capital Management LLC | 577,696 | $14.1M | 7.14% | −15,566−2.6% | Reduced |
| Millennium Management LLC | 596,056 | $14.6M | 0.01% | +347,055+139.4% | Added |
| Pictet Asset Management Holding SA | 747,829 | $18.3M | 0.02% | +73,222+10.9% | Added |
| Woodline Partners LP | 764,357 | $18.7M | 0.12% | +135,472+21.5% | Added |
| Goldman Sachs Group Inc | 767,266 | $18.8M | 0.00% | −51,401−6.3% | Reduced |
| Frazier Life Sciences Management, L.P. | 770,000 | $18.9M | 0.86% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 775,000 | $19.0M | 1.44% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 850,695 | $20.8M | 0.41% | −898−0.1% | Reduced |
| Foresite Capital Management V, LLC | 859,050 | $21.0M | 24.01% | +166,500+24.0% | Added |
| Morgan Stanley | 945,081 | $23.1M | 0.00% | +219,854+30.3% | Added |
| Avidity Partners Management LP | 980,942 | $24.0M | 4.95% | −116,858−10.6% | Reduced |
| Price T Rowe Associates Inc | 1,014,596 | $24.8M | 0.00% | +69,402+7.3% | Added |
| Polar Capital Holdings Plc | 1,042,860 | $25.5M | 0.16% | +75,805+7.8% | Added |
| Acorn Capital Advisors, LLC | 1,131,501 | $27.7M | 18.49% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,138,918 | $27.9M | 0.03% | −30,335−2.6% | Reduced |
| Geode Capital Management, LLC | 1,279,234 | $31.3M | 0.00% | +122,564+10.6% | Added |
| Franklin Resources Inc | 1,318,934 | $32.3M | 0.01% | +43,043+3.4% | Added |
| Janus Henderson Group PLC | 1,277,741 | $33.7M | 0.02% | −208,102−14.0% | Reduced |
| Point72 Asset Management, L.P. | 1,667,174 | $40.8M | 0.11% | +1,358,915+440.8% | Added |
| RTW Investments, LP | 1,701,216 | $41.7M | 0.64% | 00.0% | Unchanged |
| UBS Group AG | 1,704,718 | $41.7M | 0.01% | +690,827+68.1% | Added |
| Alliancebernstein L.P. | 1,882,577 | $46.1M | 0.02% | +64,690+3.6% | Added |
| State Street Corp | 1,967,489 | $48.2M | 0.00% | +43,905+2.3% | Added |
| Wellington Management Group LLP | 2,125,208 | $52.0M | 0.01% | +214,738+11.2% | Added |
| Foresite Capital Management VI LLC | 2,221,474 | $54.4M | 29.80% | 00.0% | Unchanged |
| Marshall Wace, LLP | 2,418,456 | $59.2M | 0.08% | +960,384+65.9% | Added |
| OrbiMed Advisors LLC | 2,471,994 | $60.5M | 1.45% | +1,040,880+72.7% | Added |
| FMR LLC | 2,545,098 | $62.3M | 0.00% | +111,505+4.6% | Added |
| Kynam Capital Management, LP | 2,611,662 | $64.0M | 5.47% | +91,957+3.6% | Added |
| Braidwell LP | 3,283,317 | $80.4M | 2.83% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 3,670,206 | $89.9M | 12.26% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,355,060 | $106.7M | 0.00% | +293,930+7.2% | Added |
| Vanguard Group Inc | 5,836,320 | $142.9M | 0.00% | −24,762−0.4% | Reduced |
| Decheng Capital LLC | 6,371,669 | $156.0M | 43.77% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −419,450−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −197,937−100.0% | Sold out |
| Pamalican Asset Management Ltd | 0 | $0 | 0.00% | −181,582−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −95,439−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −83,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −61,362−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −36,872−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,996−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −16,891−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −12,834−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,907−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −6,578−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −2,463−100.0% | Sold out |
| MRP Capital Investments, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |